← Evidence map

ReviewOncoTargets and therapy2019

Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma.

Thomas A Ollila et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30799938